MDT
84.09
-0.06%↓
VEEV
226.15
+0.17%↑
A
105.84
-0.02%↓
WBA
10.99
+0.09%↑
CHE
550.42
-2.1%↓
MDT
84.09
-0.06%↓
VEEV
226.15
+0.17%↑
A
105.84
-0.02%↓
WBA
10.99
+0.09%↑
CHE
550.42
-2.1%↓
MDT
84.09
-0.06%↓
VEEV
226.15
+0.17%↑
A
105.84
-0.02%↓
WBA
10.99
+0.09%↑
CHE
550.42
-2.1%↓
MDT
84.09
-0.06%↓
VEEV
226.15
+0.17%↑
A
105.84
-0.02%↓
WBA
10.99
+0.09%↑
CHE
550.42
-2.1%↓
MDT
84.09
-0.06%↓
VEEV
226.15
+0.17%↑
A
105.84
-0.02%↓
WBA
10.99
+0.09%↑
CHE
550.42
-2.1%↓
24 val.
Dabar
Min
1.59
Max
1.66
Rekomendacijos | Pirkti |
---|---|
12 mėnesių prognozė | +863.86% upside |
Ankstesni rezultatai nėra patikimas būsimų rezultatų rodiklis.
2025-03-10 02:12; UTC
Checkpoint Controlling Shareholder Fortress Has Agreed to Vote in Favor of Transaction >524715.BY
DJ
Skaityti
2025-03-10 02:12; UTC
Sun Pharma, Checkpoint Transaction Expected to Complete in 2Q 2025 >524715.BY
DJ
Skaityti
2025-03-10 02:11; UTC
Sun Pharma, Checkpoint, Fortress Biotech Enter Into Royalty Agreement >524715.BY
DJ
Skaityti
2025-03-10 02:11; UTC
Checkpoint Shareholders Entitled to Receive Up to Additional $0.70 if Cosibelimab if Approved in EU Prior to Certain Deadlines >524715.BY
DJ
Skaityti
2025-03-10 02:10; UTC
Checkpoint Shareholders to Receive Upfront Cash Payment of $4.10/Share, Contingent Value Right >524715.BY
DJ
Skaityti
2025-03-10 02:10; UTC
Sun Pharma to Acquire Checkpoint Therapeutics >524715.BY CKPT
DJ
Skaityti
2025-03-10 02:06; UTC
Sun Pharma To Acquire Checkpoint Therapeutics >524715.BY CKPT
DJ
Skaityti
Kainos pokytis
By TipRanks
12 mėnesių prognozė
Vidutinis 16 USD 863.86%
Aukščiausias 16 USD
Žemiausias 16 USD
Remiantis 1 „Wall Street“ analitikais, siūlančiais 12 mėnesių tikslines Fortress Biotech Inc kainas – Dist per pastaruosius 3 mėnesius.
By TipRanks
Pirkti
1 ratings
1
Pirkti
0
Laikyti
0
Parduoti
Remiantis 1 analitikų, pateikusių Fortress Biotech Inc akcijų reitingus – Dist per pastaruosius 3 mėnesius.
$